TALICIA DR 10-250-12.5 MG CAP

omeprazole magnesium, amoxicillin and rifabutin
$4.8567per EA

Strength

250; 10; 12.5 mg/1; mg/1; mg/1

NDC

57841115002

Classification

Brand

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Last Updated

1/1/2026

Approval Type

New Drug (NDA)

FDA Application

NDA213004

On Market Since

3/9/2020

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Penicillin-class Antibacterial
Penicillins
Proton Pump Inhibitor
Proton Pump Inhibitors
Rifamycin Antimycobacterial
Rifamycins

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.0%

1Y

+1.7%

3Y

+11.2%

5Y

+28.4%

All

+28.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.